Concerns About Faecal Tumour Pyruvate Kinase M2 as a Colorectal Cancer Marker
Author Information
Author(s): Shastri Y M, Stein J M
Primary Institution: St Elisabethen Hospital, Katharina Kasper Kliniken, Goethe-University, Frankfurt am Main, Germany
Conclusion
Faecal M2-PK is not a reliable biomarker for detecting colorectal adenomas.
Supporting Evidence
- Previous studies have shown that faecal M2-PK has poor sensitivity and specificity for detecting colorectal adenomas.
- The study design included patients younger than the recommended age for screening, which is a limitation.
- Exclusion of non-German speakers may introduce bias in the study results.
Takeaway
The study suggests that a test called faecal M2-PK doesn't work well for finding early signs of colon cancer.
Methodology
The study involved screening asymptomatic patients over 55 years for colorectal cancer using faecal M2-PK.
Potential Biases
Patients with insufficient knowledge of German were excluded, which may introduce bias.
Limitations
The study included patients younger than the recommended age for screening, which raises questions about its design.
Participant Demographics
Patients scheduled for colonoscopic CRC screening, primarily older than 55 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website